| Christos Ross |
Christos Ross has held multiple positions throughout his career. Currently, he is the Director at The Boston Chamber of Commerce, the Director at The New England Council, Inc., and the Senior VP-Global Operations & Waters Division at Waters Corp. In terms of education, Mr. Ross holds an MBA from the University of Washington and an undergraduate degree from Worcester Polytechnic Institute. |
| Flemming Ørnskov |
Flemming Ørnskov is currently the Chief Executive Officer at Shire Pharmaceuticals Ltd. He also holds the position of Chief Executive Officer at Galderma Benelux BV, Chairman & Chief Executive Officer at Galderma Holding SA, Chief Executive Officer at Galderma Group AG, Independent Non-Executive Chairman at Waters Corp., Chairman-Management Board at Galderma Pharma SA, Director at Biotechnology Innovation Organization, Independent Director at Karo Healthcare AB, Non-Executive Director at Swiss-American Chamber of Commerce, Director at Proactiv Skin Health Ltd., and Member-Supervisory Board at Centogene AG. Previously, Dr. Ørnskov served as the President & Chief Executive Officer at Veloxis Pharmaceuticals A, President & Chief Executive Officer at Ikaria, Inc., Chief Executive Officer & Non-Executive Director at Shire Plc, Chairman, President & Chief Executive Officer at Life Cycle Pharma A, Vice Chairman at Evotec SE, Non-Executive Chairman at Recordati SpA, Non-Executive Chairman at Astion Pharma A, Non-Executive Chairman at Evotec International GmbH, Chairman at Roche Innovation Center Copenhagen A, Non-Executive Director at PCI Biotech Holding ASA, Global President-Pharmaceuticals & OTC Division at Bausch & Lomb, Inc., Chief Marketing Officer & Global Head-General at Bayer AG, President-Global Ophthalmics Business Unit at Novartis AG, President at Bayer HealthCare AG, Analyst-Healthcare Equities at Credit Suisse Securities (Europe) Ltd., Head-General Medicine Global Business Unit at Bayer Pharma AG, and Principal at Merck & Co., Inc.Dr. Ørnskov's education includes a graduate degree from Harvard University, an MBA from INSEAD, a doctorate from the University of Copenhagen, a graduate degree from Harvard T.H. Chan School of Public Health, and a doctorate from the Faculty of Health & Medical Sciences. |
| Brook M. Colangelo |
Brook M. Colangelo is currently a Director at ISO New England, Inc., a Director at Somos, Inc., and the Chief Information Officer at Waters Corp. Previously, he served as the Chief Information Officer at The White House from 2008 to 2013 and as the Chief Information Officer & Senior Vice President at Houghton Mifflin Harcourt Co. from 2013 to 2014. He obtained his undergraduate degree from George Washington University. |
| Michael F. Silveira |
Michael F. Silveira is currently working as the Chief Accounting Officer & Corporate Controller at Waters Corp. Prior to his current position, he worked as a Controller at AstroNova, Inc., a Manager-External Reporting at Textron, Inc., and a Senior Manager at KPMG LLP. Mr. Silveira completed his undergraduate degree at Providence College. |
| Amol Chaubal |
Amol Chaubal is currently a Director at Safe Harbor Water Power Corp., RedShift Bioanalytics, Inc., Waters Technologies Corp., and Chief Financial Officer & Senior Vice President at Waters Corp. He previously worked as Vice President & Head-Finance at PAREXEL International Corp., Chief Financial Officer-Global Operations at Smith & Nephew plc, Chief Financial Officer at Quanterix Corp., CFO-North America Region & Regional COO at Brookfield Renewable Energy Group, and Chief Financial Officer-North America Region at Novartis AG. Mr. Chaubal holds an MBA from INSEAD and a graduate degree from the Indian Institute of Technology Bombay. |
| Udit Batra |
Udit Batra is currently the President, Chief Executive Officer & Director at Waters Corp. He is also the President, Chief Executive Officer & Director at Waters Technologies Corp. Additionally, he holds the position of Chairman at Massachusetts High Technology Council, Inc. and Chairman-Food Supplements Committee at the Association of the European Self-Medication Industry. Dr. Batra is a Director at the Greater Boston Chamber of Commerce, the Massachusetts Biotechnology Council, and The Boston Chamber of Commerce. Formerly, Dr. Batra served as the President, Chief Executive Officer & Director at EMD Millipore Corp. He was also the Chief Executive Officer-Life Sciences at Merck KGaA from 2014 to 2020. Dr. Batra held the position of Chief Executive Officer at Merck Consumer Health Holding GmbH and President & Chief Executive Officer at Merck Millipore Corp. Prior to that, he was the Global Head-Corporate Strategy at Novartis AG from 2006 to 2008 and the President-Pharma Business at Novartis Australia Pty Ltd. from 2008 to 2009. Dr. Batra also served as the Head-Public Health & Market Access at GSK Vaccines GmbH from 2009 to 2011. Dr. Batra holds a doctorate degree from Princeton University and an undergraduate degree from the University of Delaware. |
| Wei Jiang |
Wei Jiang is currently an Independent Director at Waters Corp. and STAAR Surgical Co. He previously worked as a Managing Director at Guidant Corp. and held leadership positions at Bayer Pharmaceuticals Corp. and Bayer Group. Mr. Jiang received his undergraduate degree from Campbell University and Indiana State University. |
| Daniel J. Brennan |
Daniel J. Brennan is an Independent Director at Waters Corp. since 2022 and at Boston Scientific Corp. since 1996, where he previously served as the Chief Financial Officer & Executive Vice President starting in 2013. He was also an Independent Director at Nuance Communications, Inc. from 2018 to 2022. Mr. Brennan holds an undergraduate degree and an MBA from Babson College. |
| Pearl Shirley Huang |
Pearl Shirley Huang was the founder of BeiGene Ltd., a company founded in 2010 where she held the title of Chief Scientific Officer from 2010 to 2012. She is currently the Chief Executive Officer at Dunad Therapeutics Ltd., starting in 2022. She is also a Director at BB Biotech AG since 2022 and an Independent Director at Waters Corp. since 2021. Additionally, she serves as a Director at MIT Corp. (United States). Previously, she was the President, Chief Executive Officer & Director at Cygnal Therapeutics, Inc. from 2019 to 2022. She also held the position of Chairman at Roche Innovation Center Copenhagen A. From 2019 to 2022, she was a Director at KSQ Therapeutics, Inc. Prior to that, she was the Senior VP & Global Head-Therapeutic Modalities at F. Hoffmann-La Roche Ltd. from 2014 to 2018 and Vice President at GSK Plc from 2012 to 2014. She has also served as an Advisor Partner at Flagship Pioneering. Dr. Huang completed her undergraduate studies at Massachusetts Institute of Technology and holds a doctorate degree from Princeton University. |
| Richard H. Fearon |
Richard H. Fearon was the founder of Willow Place Partners LLC, which was founded in 2001. He held the title of Partner in the firm in 2002. Mr. Fearon's current jobs include being the Non-Executive Chairman at Avient Corp. since 2004, Vice Chairman & Head-Finance at Playhouse Square Foundation since 2013, Independent Director at Waters Corp. since 2023, Independent Non-Executive Director at CRH Plc since 2020, Independent Director at Crown Holdings, Inc. since 2019, Director at Illumination Management Solutions, Inc., Director at E.A. Pedersen Co., Director at Manufacturers Alliance, President at Eaton US Holdings, Inc., Member at The State Bar of California, Trustee at The Cleveland Museum of Art, and Advisor at UH Ventures LLC. Mr. Fearon's former jobs include being the Vice Chairman, Chief Financial & Planning Officer at Eaton Corp. Plc from 2012 to 2021, Chairman-CFO Council at MAPI, Inc. in 2014, Director-Strategic Planning at The Walt Disney Co., Director at Southern Steel Bhd., Director & Vice President at Cooper Crouse-Hinds MTL, Inc., Director at Centurion Industries Ltd., Director at Hawken School, Lead Independent Director at Hennessy Capital Investment Corp. VI, Chief Financial & Planning Officer at Eaton Corp. from 2002 to 2009, Senior Vice President-Corporate Development at Transamerica Corp. from 1995 to 2000, General Manager at NSL Ltd., and General Manager-Corporate Development at NSL Chemicals Ltd. from 1990 to 2000. He was also a Member of the California State Bar Association. Mr. Fearon's education includes an undergraduate degree from Stanford University, an MBA from Harvard Business School, and a graduate degree from Harvard Law School. |
| Christopher A. Kuebler |
Christopher A. Kuebler is an Independent Director at Waters Corp. since 2006. He was the Chairman at Labcorp Drug Development, Inc. from 2004 to 2005. He was also an Independent Director at Nektar Therapeutics from 2001 to 2018. Prior to that, he was the Vice President-European Operations at Abbott Laboratories from 1986 to 1993. He completed his undergraduate degree from Florida State University. |
| Mark P. Vergnano |
Mark P. Vergnano is the Founding Chairman of the Vergnano Institute at the University of Connecticut. He is also a Director at Johnson Controls, Inc. and an Independent Director at Waters Corp. Additionally, he serves as a Director for The Delaware Council for Economic Education, Inc., is a Member of the Hall of Fame, and a Member of the Academy of Distinguished Engineers at the School of Engineering (Connecticut). Previously, he served as Chairman of The Chemours Co., Chairman of the National Safety Council, and Vice President at EIDP, Inc., The DuPont Safety & Protection, and DuPont Nonwovens, Inc. He has also served as a Director for MEGA Brands, Inc., the National Association of Manufacturers, and the American Chemistry Council, Inc. Mr. Vergnano received his undergraduate degree from the University of Connecticut and his MBA from Virginia Commonwealth University. |
| Linda Baddour |
Linda Baddour is currently an Independent Director at Waters Corp., CryoPort, Inc., Advarra, Inc., Signant Health, Buccaneer Holdco Ltd., and SAB Healthcare at Genstar Capital Management LLC. She also served as the Chief Financial Officer & Vice President at Pharmaceutical Research Associates, Inc. Ms. Baddour's former positions include Chief Financial & Accounting Officer at Pharmaceutical Product Development LLC, Secretary & Executive Vice President at PRA Health Sciences, Inc., Chief Financial Officer at Product Development Technologies LLC, and Controller at Cooperative Bank (Wilmington, North Carolina). Ms. Baddour earned an undergraduate degree and an MBA from The University of North Carolina at Wilmington. |
